tirzepatide lawsuit update Trulicity [2026] Eli Lilly joins FDA as
Description
Patients and clinicians are encouraged to: Report any new neurological or haematological symptoms promptly to a GP, and seek urgent assessment if neurological symptoms are present Discuss nutritional supplementation as part of the initial treatment consultation Refer to a dietitian where dietary intake is significantly restricted or where multiple deficiencies are identified Report suspected adverse drug reactions including any nutritional concerns potentially related to retatrutide via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk) Stay informed as MHRA and NICE guidance evolves following any future licensing decision for retatrutide Proactive nutritional monitoring is a cornerstone of safe, responsible prescribing for any medicine that substantially alters dietary behaviour, and retatrutide should be no exception
![tirzepatide lawsuit update Trulicity [2026] Eli Lilly joins FDA as](https://static.wixstatic.com/media/11062b_dbc05a84db5f43b8bbb5b2e3a546bfa2~mv2.jpeg/v1/fill/w_568,h_290,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/11062b_dbc05a84db5f43b8bbb5b2e3a546bfa2~mv2.jpeg)
That means a 200 lb person lost 30 pounds on the medication
![tirzepatide lawsuit update Trulicity [2026] Eli Lilly joins FDA as](https://news-api.bloomberglaw.com/v1/resize-image?url=https%3A%2F%2Fbloomberg-bna-brightspot.s3.us-east-1.amazonaws.com%2Fe2%2F54%2F109a006d47dcb7742f2d2281df96%2Fgettyimages-2059065621.jpg&width=1240&height=480&fit=cover&crop=4901x1889%2B4%2B990)
because of the long (11 weeks) dose titration period and the primary outcome being measured during the following 4 weeks, participants had 13 weeks of functional washout period
![tirzepatide lawsuit update Trulicity [2026] Eli Lilly joins FDA as](https://cdn.patentlyo.com/media/2025/02/mounjaro2-1024x512.jpg)
When stool remains in the colon for too long, it can become hard and difficult to pass
![tirzepatide lawsuit update Trulicity [2026] Eli Lilly joins FDA as](https://www.torhoermanlaw.com/wp-content/uploads/2024/06/Do-You-Qualify-for-the-Ozempic-Stomach-Paralysis-Lawsuit.jpg)
Key points included: Weight stigma influences how patients are assessed, diagnosed, and treated Patients in larger bodies may receive delayed or inappropriate care Fear of judgment can lead patients to avoid healthcare settings Weight stigma is not neutral, and it directly affects clinical outcomes